Latest topics page 45
Topics ordered by most recent activity across all 71 subcategories.
1,535 topics · page 45 of 52
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Coming back to: Recording a dissent on a document rather than suppressing it
Posting this under the heading it deserves: Recording a dissent on a document rather than suppressing it Everything below is what sits behind that. Process question about how this site works. I have read the…
|
+43 | 47 | 11k | 16mo |
|
Coming back to: GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Writing it up because I had to work it out twice and would rather nobody else did. I have seen SURPASS-4 ( Lancet , 2021)…
|
+9 | 13 | 249 | 17mo |
|
Anaesthesia and elective surgery: the aspiration question — does this still hold?
Anaesthesia and elective surgery: the aspiration question — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below. Practical question with the units…
|
+23 | 27 | 5.6k | 17mo |
|
Why side effects reset at each escalation and that is not a failure — the long version
The question in the title: Why side effects reset at each escalation and that is not a failure — the long version I will give what I have already checked below so nobody repeats it. Reporting something rather…
|
2 | 46k | 17mo | |
|
Consistent declarations and why they matter more than clever ones
Consistent declarations and why they matter more than clever ones — setting out what I have, and where I think it stops being reliable. A logistics question, since the answers here are usually better than…
|
+146 | 164 | 2k | 17mo |
|
What a seizure notice actually says
What a seizure notice actually says I have a specific reason for asking rather than idle curiosity, and the context is below. A logistics question, since the answers here are usually better than anywhere else…
|
+36 | 40 | 568 | 17mo |
|
Revisiting: Bug report: the reconstitution calculator and a rounding edge case
Revisiting: Bug report: the reconstitution calculator and a rounding edge case — setting out what I have, and where I think it stops being reliable. Working through the identity arithmetic and I would like it…
|
+109 | 122 | 5.8k | 17mo |
|
Why mass spectrometry cannot tell you about an epimer
Why mass spectrometry cannot tell you about an epimer I have a specific reason for asking rather than idle curiosity, and the context is below. Posting the method first, because I know what the first three…
|
+75 | 82 | 4k | 17mo |
|
Prior authorisation: what the criteria usually require
On the subject in the title: Prior authorisation: what the criteria usually require Working notes rather than a conclusion. A coverage question with the paperwork detail included, since that is what…
|
+9 | 13 | 3.2k | 17mo |
|
Revisiting: Aggregate verification data across the directory, with caveats
Revisiting: Aggregate verification data across the directory, with caveats — setting out what I have, and where I think it stops being reliable. I would like to talk about documentation quality as a signal,…
|
+22 | 26 | 23k | 17mo |
|
Titrating on tolerability rather than on the calendar — the long version
Titrating on tolerability rather than on the calendar — the long version Writing it up because I had to work it out twice and would rather nobody else did. Reporting something rather than asking about it, in…
|
2 | 7.7k | 17mo | |
|
Retatrutide's phase 2 heart-rate signal and how to think about it — the long version
Retatrutide's phase 2 heart-rate signal and how to think about it — the long version Writing it up because I had to work it out twice and would rather nobody else did. I have seen SURMOUNT-OSA ( N Engl J Med…
|
2 | 103 | 17mo | |
|
Pharmaceutical compounding rules, summarised from primary sources
Pharmaceutical compounding rules, summarised from primary sources — setting out what I have, and where I think it stops being reliable. Structured report rather than an opinion, following the format the…
|
+135 | 163 | 46k | 17mo |
|
Second pass at: Regression to the mean in progress reports
Second pass at: Regression to the mean in progress reports Writing it up because I had to work it out twice and would rather nobody else did. Comparing SUSTAIN 6 ( N Engl J Med , 2016) with STEP 4 ( JAMA ,…
|
+71 | 75 | 4k | 17mo |
|
Second pass at: Albumin binding and how it produces a long half-life
Posting this under the heading it deserves: Second pass at: Albumin binding and how it produces a long half-life Everything below is what sits behind that. I would like to understand what this number means…
|
+7 | 11 | 31k | 17mo |
|
Specification in the result column: why that is a meaningful error — the long version
Specification in the result column: why that is a meaningful error — the long version Writing it up because I had to work it out twice and would rather nobody else did. Posting the method first, because I…
|
+14 | 18 | 12k | 17mo |
|
Coming back to: How to tell whether your question is already answered on a maintained page
How to tell whether your question is already answered on a maintained page I have a specific reason for asking rather than idle curiosity, and the context is below. Question in the title. Context below, and I…
|
2 | 808 | 17mo | |
|
SNAC and the mechanism of oral peptide absorption
On the subject in the title: SNAC and the mechanism of oral peptide absorption Working notes rather than a conclusion. Comparing SELECT ( N Engl J Med , 2023) with SURPASS-4 ( Lancet , 2021) and finding the…
|
+13 | 17 | 14k | 17mo |
|
What we do not know about retatrutide, listed explicitly
The question in the title: What we do not know about retatrutide, listed explicitly I will give what I have already checked below so nobody repeats it. Comparing FLOW ( N Engl J Med , 2024) with SURMOUNT-OSA…
|
+106 | 113 | 4.8k | 17mo |
|
Coming back to: Official shortage notices and what they authorise
Official shortage notices and what they authorise — setting out what I have, and where I think it stops being reliable. A coverage question with the paperwork detail included, since that is what determines…
|
+39 | 43 | 510 | 17mo |
|
A request that was declined, and the reasoning
On the subject in the title: A request that was declined, and the reasoning Working notes rather than a conclusion. Process question about how this site works. I have read the guidelines and the trust-level…
|
2 | 33k | 17mo | |
|
Isotope patterns and why the monoisotopic peak is not the tallest
Isotope patterns and why the monoisotopic peak is not the tallest — setting out what I have, and where I think it stops being reliable. Working through the identity arithmetic and I would like it checked.…
|
+12 | 16 | 7.5k | 17mo |
|
Distinguishing a deletion sequence by mass alone
Distinguishing a deletion sequence by mass alone Writing it up because I had to work it out twice and would rather nobody else did. Working through the identity arithmetic and I would like it checked.…
|
+121 | 129 | 25k | 17mo |
|
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Writing it up because I had to work it out twice and would rather nobody else did. Session topic: SURPASS-4 ( Lancet , 2021). Please read it before…
|
+126 | 138 | 31k | 17mo |
|
Revisiting: Heart failure with preserved ejection fraction: symptom endpoints
On the subject in the title: Revisiting: Heart failure with preserved ejection fraction: symptom endpoints Working notes rather than a conclusion. General question, not a request for advice about my own care…
|
+4 | 8 | 43k | 17mo |
|
Biased agonism: a real phenomenon, an over-used explanation — what changed since
Biased agonism: a real phenomenon, an over-used explanation — what changed since — setting out what I have, and where I think it stops being reliable. A documentation question rather than an analytical one. I…
|
+49 | 56 | 47k | 17mo |
|
Semaglutide in people without diabetes: what the evidence base looks like
Semaglutide in people without diabetes: what the evidence base looks like Writing it up because I had to work it out twice and would rather nobody else did. Session topic: SUSTAIN 6 ( N Engl J Med , 2016).…
|
+2 | 6 | 18k | 17mo |
|
Follow-up: Attributing a new peak: degradation product or excipient?
Attributing a new peak: degradation product or excipient? I have a specific reason for asking rather than idle curiosity, and the context is below. Posting the method first, because I know what the first…
|
+15 | 19 | 671 | 17mo |
|
Amylin and gastric emptying: overlapping mechanisms with incretins
On the subject in the title: Amylin and gastric emptying: overlapping mechanisms with incretins Working notes rather than a conclusion. Session topic: STEP 2 ( Lancet , 2021). Please read it before posting;…
|
2 | 50k | 17mo | |
|
Coming back to: Reading a meta-analysis you disagree with, fairly
Reading a meta-analysis you disagree with, fairly Writing it up because I had to work it out twice and would rather nobody else did. I have seen STEP 1 ( N Engl J Med , 2021) cited in support of a claim I do…
|
+30 | 34 | 9.3k | 17mo |